Publicatie

Publicatie datum

Effects of the proactive interdisciplinary self-management (PRISMA) program on online care platform usage in patients with type 2 diabetes in primary care: a randomized controlled trial.

Pon, E. du, Kleefstra, N., Cleveringa, F., Dooren, A. van, Heerdink, E.R., Dulmen, S. van. Effects of the proactive interdisciplinary self-management (PRISMA) program on online care platform usage in patients with type 2 diabetes in primary care: a randomized controlled trial. Journal of Diabetes Research: 2020(5013142), 10 p.
Lees online
Objective:
Online care platforms can support patients with type 2 diabetes (T2DM) in managing their health. However, in the use of eHealth, a low participation rate is common. The Proactive Interdisciplinary Self-Management (PRISMA) program, aimed at improving patients' self-management skills, was expected to encourage patients to manage their disease through the use of an online platform. Therefore, the objective of the current study was to investigate whether a group education program can improve the use of an online care platform in patients with T2DM treated by primary care providers in the Netherlands.

Mehod:
In a randomized controlled trial, patients with T2DM received either PRISMA with usual care or usual care only. During a six-month follow-up period in 2014-2015, usage (number of log-ons and time spent per session) of an online care platform (e-Vita) aimed at improving T2DM self-management was assessed. A training about the functionalities of e-Vita was offered. The sample consisted of 203 patients.

Results:
No differences were found between the intervention and control groups in the number of patients who attended the platform training (interested patients) (X2ð1Þ = 0:58; p = 0:45), and the number of patients who logged on at least once (platform users) (X2ð1Þ = 0:46; p = 0:50). In addition, no differences were found between the groups in the type of users—patients who logged on twice or more (active users) or patients who logged on once (nonactive users) (X2ð1Þ = 0:56; p = 0:45).

Conclusion:
The PRISMA program did not change platform usage in patients with T2DM. In addition, only a small proportion of the patients logged on twice or more. Patients probably need other encouragements to manage their condition using an online platform.